Active Ingredient(s): Naratriptan
FDA Approved: * February 10, 1998
Category: Migraine / Tension Headache

Naratriptan (trade names include Amerge) is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. It is a selective 5-HT1 receptor subtype agonist. It was patented in 1987 and approved for medical use in 1997.[1] Contents 1 Medical uses 1.1 Efficacy 2 Side effects 3 Mechanism of action 4 Society and culture 5 References Medical uses Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migrai... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Amerge GX;CE3
Amerge 1 mg Oral Tablet
NDC: 0173-0561
Glaxosmithkline LLC
Amerge GX;CE5
Amerge 2.5 mg Oral Tablet
NDC: 0173-0562
Glaxosmithkline LLC